Value of routine blood count surveillance in detecting relapse in acute lymphoblastic leukemia
BackgroundChildren with acute lymphoblastic leukemia (ALL) have excellent outcomes, with >85% survival without relapse following contemporary therapies. Clinical and complete blood count (CBC) assessments are commonly used surveillance methods to detect relapses. We aimed to evaluate the effi...
Saved in:
Main Authors: | Sarah AlHarbi, Areej Taha, Ahmed Ashi, Naglla Elimam, Sami Althubaiti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2024.1488686/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
by: Jin Yin, et al.
Published: (2024-12-01) -
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
by: Tingting Yang, et al.
Published: (2025-01-01) -
Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study
by: Eri Ushida, et al.
Published: (2025-01-01) -
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01) -
Systemic xanthogranuloma involving bone marrow and skin in a case of B-Lymphoblastic Leukemia
by: Manasi C. Mundada, et al.
Published: (2023-01-01)